gms | German Medical Science

129. Kongress der Deutschen Gesellschaft für Chirurgie

Deutsche Gesellschaft für Chirurgie

24.04. - 27.04.2012, Berlin

Resection vs. Transplantation as Curative Treatment Options for Hepatocellular Carcinoma in Cirrhosis – Systematic Review

Meeting Abstract

  • Andrea Proneth - Universitätsklinikum Regensburg, Klinik und Poliklinik für Chirurgie, Regensburg
  • Sven Lang - Universitätsklinikum Regensburg, Klinik und Poliklinik für Chirurgie, Regensburg
  • Stefan Farkas - Universitätsklinikum Regensburg, Klinik und Poliklinik für Chirurgie, Regensburg
  • Marcus Scherer - Universitätsklinikum Regensburg, Klinik und Poliklinik für Chirurgie, Regensburg
  • Martin Loss - Universitätsklinikum Regensburg, Klinik und Poliklinik für Chirurgie, Regensburg
  • Edward K. Geissler - Universitätsklinikum Regensburg, Klinik und Poliklinik für Chirurgie, Regensburg
  • Hans Jürgen Schlitt - Universitätsklinikum Regensburg, Klinik und Poliklinik für Chirurgie, Regensburg
  • Andreas A. Schnitzbauer - Universitätsklinikum Regensburg, Klinik und Poliklinik für Chirurgie, Regensburg

Deutsche Gesellschaft für Chirurgie. 129. Kongress der Deutschen Gesellschaft für Chirurgie. Berlin, 24.-27.04.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. Doc12dgch147

DOI: 10.3205/12dgch147, URN: urn:nbn:de:0183-12dgch1475

Veröffentlicht: 23. April 2012

© 2012 Proneth et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Einleitung: To systematically review the literature on resection (Rx) and liver transplantation (LT) for hepatocellular carcinoma (HCC) in patients with Child A cirrhosis.

Hepatocellular Carcinoma is the fifth most neoplasm worldwide. Current standard curative therapeutic strategies include resection and liver transplantation with or without prior bridging with ablative procedures. Organ shortage leads to discussion whether HCC should be transplanted or whether resection can achieve similar results.

Material und Methoden: A systematic review of various databases (Pubmed, PICO, MEDLINE, Cochrane and Library for RCT) was performed. Studies investigating Rx vs. LT, and Rx or LT only, and in which patients were regarded to be both resectable and transplantable between 1998 and 2011 were included in the analysis. The primary endpoint was overall survival (OS). Secondary endpoints were disease free survival (DFS) as well as prognostic factors (AFP, tumor size and number, micro- and macrovascular invasion, stadium of cirrhosis, MELD-score, bridging therapies etc.). The results should serve as a decision-making basis to either transplant or resect the patient primarily in case of HCC-diagnosis.

Ergebnisse: Database research revealed a total 843 hits. To date there is no existing randomized controlled trial (RCT) investigating Rx vs. Tx for HCC. A total of 71 publications were eligible for statistical evaluation. OS and DFS data for LT and Rx differ significantly between groups favoring LT. However, surrogate predictive markers for outcome reveal a lower microvascular invasion, a better differentiation, less microsatellites, smaller tumors and lower pre-treatment AFP values in patients being transplanted.

Schlussfolgerung: Current evidence in literature does not allow a meaningful comparison between patient collectives undergoing Rx or LT for HCC. There are no data from randomized controlled trials. Analyses do not compare patients in a comparable tumor stadium. A RCT in patients without contraindications for transplantation or resection and comparable surrogate characteristics should be initiated investigating the hypothesis that resection of HCC achieves similar results than transplantation.